$SLS
SELLAS Life Sciences Group, Inc.

2015 Q4 Form 10-K Financial Statement

#000139047816000088 Filed on March 10, 2016

View on sec.gov

Income Statement

Concept 2015 Q4 2014 Q4 2013 Q4
Revenue $0.00 $3.200M $1.436M
YoY Change -100.0% 122.84% 0.0%
Cost Of Revenue $480.0K $220.0K
YoY Change 118.18%
Gross Profit $2.720M $1.229M
YoY Change 121.32% 0.0%
Gross Profit Margin 85.0% 85.58%
Selling, General & Admin $2.740M $7.650M $6.230M
YoY Change -64.18% 22.79% 323.81%
% of Gross Profit 281.25% 506.92%
Research & Development $4.850M $6.270M $7.090M
YoY Change -22.65% -11.57% 72.51%
% of Gross Profit 230.51% 576.89%
Depreciation & Amortization -$190.0K $20.00K $120.0K
YoY Change -1050.0% -83.33%
% of Gross Profit 0.74% 9.76%
Operating Expenses $7.590M $14.10M $13.45M
YoY Change -46.17% 4.83% 141.04%
Operating Profit -$11.38M -$12.22M
YoY Change -6.88% 180.88%
Interest Expense $1.990M $3.200M -$34.66M
YoY Change -37.81% -109.23%
% of Operating Profit
Other Income/Expense, Net $440.0K $230.0K -$380.0K
YoY Change 91.3% -160.53% -149.35%
Pretax Income -$10.44M -$7.960M -$47.39M
YoY Change 31.16% -83.2% 887.29%
Income Tax $370.0K $0.00 $1.110M
% Of Pretax Income
Net Earnings -$19.68M -$7.960M -$5.516M
YoY Change 147.24% 44.31% -71.97%
Net Earnings / Revenue -248.75% -384.12%
Basic Earnings Per Share -$0.51
Diluted Earnings Per Share -$1.968B -$1.921B -$13.64B
COMMON SHARES
Basic Shares Outstanding 161.9M shares 121.5M shares 105.2M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2014 Q4 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.70M $23.70M $47.79M
YoY Change 25.32% -50.4% 34.67%
Cash & Equivalents $1.397M $23.65M $47.79M
Short-Term Investments $0.00
Other Short-Term Assets $23.90M $28.40M $1.600M
YoY Change -15.85% 1675.0% 166.67%
Inventory $0.00 $655.0K $386.0K
Prepaid Expenses
Receivables $1.839M $3.683M
Other Receivables $0.00
Total Short-Term Assets $53.62M $52.10M $68.79M
YoY Change 2.92% -24.26% 90.43%
LONG-TERM ASSETS
Property, Plant & Equipment $335.0K $285.0K $314.0K
YoY Change 17.54% -9.24% 982.76%
Goodwill $5.898M $5.897M $5.898M
YoY Change 0.02% -0.02% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $100.0K $100.0K
YoY Change 100.0% 0.0% 0.0%
Total Long-Term Assets $28.52M $28.39M $19.19M
YoY Change 0.48% 47.92% 1.73%
TOTAL ASSETS
Total Short-Term Assets $53.62M $52.10M $68.79M
Total Long-Term Assets $28.52M $28.39M $19.19M
Total Assets $82.14M $80.49M $87.98M
YoY Change 2.06% -8.51% 60.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.597M $1.886M $1.907M
YoY Change -15.32% -1.1% -3.49%
Accrued Expenses $5.292M $8.885M $4.841M
YoY Change -40.44% 83.54% 137.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.739M $3.910M $2.149M
YoY Change 21.2% 81.95%
Total Short-Term Liabilities $57.07M $27.23M $62.47M
YoY Change 109.57% -56.41% 292.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $4.492M $7.743M
YoY Change -100.0% -41.99%
Other Long-Term Liabilities $6.100M $6.700M $6.800M
YoY Change -8.96% -1.47% 9.68%
Total Long-Term Liabilities $0.00 $4.492M $7.743M
YoY Change -100.0% -41.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $57.07M $27.23M $62.47M
Total Long-Term Liabilities $0.00 $4.492M $7.743M
Total Liabilities $68.63M $43.43M $82.09M
YoY Change 58.03% -47.1% 201.47%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $296.7M $256.4M $188.6M
YoY Change 15.74% 35.94% 42.7%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.849M $3.849M $3.849M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 33.75K shares 675.0K shares 675.0K shares
Shareholders Equity -$12.26M $37.06M $5.886M
YoY Change
Total Liabilities & Shareholders Equity $82.14M $80.49M $87.98M
YoY Change 2.06% -8.51% 60.0%

Cashflow Statement

Concept 2015 Q4 2014 Q4 2013 Q4
OPERATING ACTIVITIES
Net Income -$19.68M -$7.960M -$5.516M
YoY Change 147.24% 44.31% -71.97%
Depreciation, Depletion And Amortization -$190.0K $20.00K $120.0K
YoY Change -1050.0% -83.33%
Cash From Operating Activities -$15.28M -$10.73M -$8.490M
YoY Change 42.4% 26.38% 64.22%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K -$110.0K -$5.220M
YoY Change -36.36% -97.89%
Acquisitions $10.00M
YoY Change
Other Investing Activities $11.29M $0.00 $2.420M
YoY Change -100.0%
Cash From Investing Activities $11.22M -$110.0K -$2.800M
YoY Change -10300.0% -96.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.000M 9.850M 7.690M
YoY Change -110.15% 28.09% -65.91%
NET CHANGE
Cash From Operating Activities -15.28M -10.73M -8.490M
Cash From Investing Activities 11.22M -110.0K -2.800M
Cash From Financing Activities -1.000M 9.850M 7.690M
Net Change In Cash -5.060M -990.0K -3.600M
YoY Change 411.11% -72.5% -120.7%
FREE CASH FLOW
Cash From Operating Activities -$15.28M -$10.73M -$8.490M
Capital Expenditures -$70.00K -$110.0K -$5.220M
Free Cash Flow -$15.21M -$10.62M -$3.270M
YoY Change 43.22% 224.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 gale Operating Loss Carryforwards Exerciseof Stock Options
OperatingLossCarryforwardsExerciseofStockOptions
1400000 USD
CY2013Q3 gale Proceeds From Issuanceor Saleof Equity Net Underwriting Discounts Commissionsand Offering Expenses
ProceedsFromIssuanceorSaleofEquityNetUnderwritingDiscountsCommissionsandOfferingExpenses
37500000 USD
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001390478
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
181746561 shares
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q2 dei Entity Public Float
EntityPublicFloat
275097000 USD
CY2015 dei Entity Registrant Name
EntityRegistrantName
Galena Biopharma, Inc.
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Trading Symbol
TradingSymbol
GALE
CY2013 gale Aggregate Intrinsic Value Of Stock Options Exercisable
AggregateIntrinsicValueOfStockOptionsExercisable
890000 USD
CY2014 gale Aggregate Intrinsic Value Of Stock Options Exercisable
AggregateIntrinsicValueOfStockOptionsExercisable
13429000 USD
CY2015 gale Aggregate Intrinsic Value Of Stock Options Exercisable
AggregateIntrinsicValueOfStockOptionsExercisable
37000 USD
CY2015 gale Amortization Period Of Selling And Distribution Rights
AmortizationPeriodOfSellingAndDistributionRights
P10Y
CY2013 gale Cash Excluding From Net Assets Acquired
CashExcludingFromNetAssetsAcquired
168000 USD
CY2013 gale Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings
ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings
-44001000 USD
CY2014 gale Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings
ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings
16556000 USD
CY2015 gale Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings
ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings
1161000 USD
CY2013 gale Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
-926000 USD
CY2014 gale Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
170000 USD
CY2015 gale Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
509000 USD
CY2013 gale Change In Fair Value Of Contingent Purchase Price Consideration
ChangeInFairValueOfContingentPurchasePriceConsideration
926000 USD
CY2014 gale Change In Fair Value Of Contingent Purchase Price Consideration
ChangeInFairValueOfContingentPurchasePriceConsideration
-170000 USD
CY2015 gale Change In Fair Value Of Contingent Purchase Price Consideration
ChangeInFairValueOfContingentPurchasePriceConsideration
-509000 USD
CY2014 gale Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-16556000 USD
CY2015 gale Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-1161000 USD
CY2014 gale Fair Value Of Contingent Purchase Price Consideration
FairValueOfContingentPurchasePriceConsideration
2716000 USD
CY2015 gale Fair Value Of Contingent Purchase Price Consideration
FairValueOfContingentPurchasePriceConsideration
0 USD
CY2014 gale Fair Value Of Warrants Exercised
FairValueOfWarrantsExercised
27026000 USD
CY2015 gale Fair Value Of Warrants Exercised
FairValueOfWarrantsExercised
0 USD
CY2015 gale Employee Service Share Based Compensation Unrecognized Compensation Costs Weighted Average Period Of Recognition
EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsWeightedAveragePeriodOfRecognition
P2Y10M6D
CY2015 gale Estimated Annualized Forfeiture Rate For Options Granted To Employees
EstimatedAnnualizedForfeitureRateForOptionsGrantedToEmployees
0.15
CY2015 gale Estimated Annualized Forfeiture Rate For Options Granted To Senior Management
EstimatedAnnualizedForfeitureRateForOptionsGrantedToSeniorManagement
0.08
CY2013 gale Fair Value Of Contingent Purchase Price Consideration
FairValueOfContingentPurchasePriceConsideration
0 USD
CY2014 gale Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
5694000 shares
CY2015 gale Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2013Q2 gale Classof Warrantor Right Average Market Price Used For Exercise Price
ClassofWarrantorRightAverageMarketPriceUsedForExercisePrice
P20D
CY2014 gale Classof Warrantor Right Expired
ClassofWarrantorRightExpired
916000 shares
CY2015 gale Classof Warrantor Right Expired
ClassofWarrantorRightExpired
238000 shares
CY2014 gale Classof Warrantor Right Granted
ClassofWarrantorRightGranted
300000 shares
CY2015 gale Classof Warrantor Right Granted
ClassofWarrantorRightGranted
14006000 shares
CY2013Q2 gale Classof Warrantor Right Term
ClassofWarrantorRightTerm
P7Y
CY2013 gale Common Stock Issued In Connection With Espp
CommonStockIssuedInConnectionWithEspp
-163000 USD
CY2014 gale Common Stock Issued In Connection With Espp
CommonStockIssuedInConnectionWithEspp
-263000 USD
CY2015 gale Common Stock Issued In Connection With Espp
CommonStockIssuedInConnectionWithEspp
-309000 USD
CY2014Q4 gale Contingent Purchase Price Consideration Net Of Current Portion
ContingentPurchasePriceConsiderationNetOfCurrentPortion
6651000 USD
CY2015Q4 gale Contingent Purchase Price Consideration Net Of Current Portion
ContingentPurchasePriceConsiderationNetOfCurrentPortion
6142000 USD
CY2014Q4 gale Contract Research Payable
ContractResearchPayable
6967000 USD
CY2015Q4 gale Contract Research Payable
ContractResearchPayable
3294000 USD
CY2015Q4 gale Contractual Obligations Current Due
ContractualObligationsCurrentDue
10507000 USD
CY2013Q2 gale Debt Instrument Cash Facility Fee
DebtInstrumentCashFacilityFee
0.01
CY2013Q2 gale Debt Instrument Cash Final Payment
DebtInstrumentCashFinalPayment
0.055
CY2013Q2 gale Debt Instrument Term Interest Only
DebtInstrumentTermInterestOnly
P12M
CY2014Q4 gale Deferred Tax Assets Licensing Deduction Deferral
DeferredTaxAssetsLicensingDeductionDeferral
8919000 USD
CY2015Q4 gale Deferred Tax Assets Licensing Deduction Deferral
DeferredTaxAssetsLicensingDeductionDeferral
9910000 USD
CY2014Q4 gale Deficit Accumulated During Developmental Stage
DeficitAccumulatedDuringDevelopmentalStage
-215481000 USD
CY2015Q4 gale Deficit Accumulated During Developmental Stage
DeficitAccumulatedDuringDevelopmentalStage
-279383000 USD
CY2015 gale Employee Service Share Based Compensation Unrecognized Compensation Costs
EmployeeServiceShareBasedCompensationUnrecognizedCompensationCosts
5662000 USD
CY2013 gale Fair Value Of Warrants Issued In Connection With Common Stock Recorded As Cost Of Equity
FairValueOfWarrantsIssuedInConnectionWithCommonStockRecordedAsCostOfEquity
8238000 USD
CY2015 gale Fair Value Of Warrants Issued In Connection With Common Stock Recorded As Cost Of Equity
FairValueOfWarrantsIssuedInConnectionWithCommonStockRecordedAsCostOfEquity
10296000 USD
CY2013Q4 gale Fair Value Of Warrants Liabilities
FairValueOfWarrantsLiabilities
48965000 USD
CY2014Q4 gale Fair Value Of Warrants Liabilities
FairValueOfWarrantsLiabilities
5383000 USD
CY2015Q4 gale Fair Value Of Warrants Liabilities
FairValueOfWarrantsLiabilities
14518000 USD
CY2014Q4 gale Fair Value Of Warrants Potentially Settleable In Cash
FairValueOfWarrantsPotentiallySettleableInCash
5383000 USD
CY2015Q4 gale Fair Value Of Warrants Potentially Settleable In Cash
FairValueOfWarrantsPotentiallySettleableInCash
14518000 USD
CY2014 gale Fair Valueof Warrants Granted
FairValueofWarrantsGranted
0 USD
CY2015 gale Fair Valueof Warrants Granted
FairValueofWarrantsGranted
10296000 USD
CY2013Q2 gale Fair Valueof Warrants Grantedper Share
FairValueofWarrantsGrantedperShare
1.93
CY2015Q4 gale Future Milestone Payment
FutureMilestonePayment
5000000 USD
CY2015 gale Future Milestone Payment After Phase One
FutureMilestonePaymentAfterPhaseOne
500000 USD
CY2015 gale Future Milestone Payment After Phase Two
FutureMilestonePaymentAfterPhaseTwo
250000 USD
CY2015 gale Future Milestone Payment After Phase Two Payment Period
FutureMilestonePaymentAfterPhaseTwoPaymentPeriod
P30D
CY2015Q4 gale Longterm Debt Netof Unamortized Issuance Costs
LongtermDebtNetofUnamortizedIssuanceCosts
4739000 USD
CY2015Q4 gale Loss Contingency Damages Paidby Insurance Company Value
LossContingencyDamagesPaidbyInsuranceCompanyValue
21700000 USD
CY2014Q4 gale Gale401rights
GALE401rights
9255000 USD
CY2015Q4 gale Gale401rights
GALE401rights
9255000 USD
CY2013 gale General And Administrative Expenses
GeneralAndAdministrativeExpenses
8065000 USD
CY2014 gale General And Administrative Expenses
GeneralAndAdministrativeExpenses
16226000 USD
CY2015 gale General And Administrative Expenses
GeneralAndAdministrativeExpenses
10609000 USD
CY2014Q4 gale In Process Research Development
InProcessResearchDevelopment
12864000 USD
CY2015Q4 gale In Process Research Development
InProcessResearchDevelopment
12864000 USD
CY2013 gale Income Tax Reconciliation Gain On Change In Fair Value Of Warrant Liability
IncomeTaxReconciliationGainOnChangeInFairValueOfWarrantLiability
17283000 USD
CY2014 gale Income Tax Reconciliation Gain On Change In Fair Value Of Warrant Liability
IncomeTaxReconciliationGainOnChangeInFairValueOfWarrantLiability
-6503000 USD
CY2015 gale Income Tax Reconciliation Gain On Change In Fair Value Of Warrant Liability
IncomeTaxReconciliationGainOnChangeInFairValueOfWarrantLiability
-456000 USD
CY2013 gale Income Tax Reconciliation Unrealized Gain On Marketable Securities
IncomeTaxReconciliationUnrealizedGainOnMarketableSecurities
1052000 USD
CY2014 gale Income Tax Reconciliation Unrealized Gain On Marketable Securities
IncomeTaxReconciliationUnrealizedGainOnMarketableSecurities
0 USD
CY2015 gale Income Tax Reconciliation Unrealized Gain On Marketable Securities
IncomeTaxReconciliationUnrealizedGainOnMarketableSecurities
0 USD
CY2015Q4 gale Increase Decrease Deferred Tax Assets
IncreaseDecreaseDeferredTaxAssets
600000 USD
CY2013 gale Increase Decreasein Litigation Settlement
IncreaseDecreaseinLitigationSettlement
0 USD
CY2014 gale Increase Decreasein Litigation Settlement
IncreaseDecreaseinLitigationSettlement
0 USD
CY2015 gale Increase Decreasein Litigation Settlement
IncreaseDecreaseinLitigationSettlement
24000000 USD
CY2013 gale Interest Income
InterestIncome
-807000 USD
CY2014 gale Interest Income
InterestIncome
-1110000 USD
CY2015 gale Interest Income
InterestIncome
-760000 USD
CY2013 gale Issuance Of Common Stock In Exchange Of Outstanding Warrants
IssuanceOfCommonStockInExchangeOfOutstandingWarrants
0 USD
CY2014 gale Issuance Of Common Stock In Exchange Of Outstanding Warrants
IssuanceOfCommonStockInExchangeOfOutstandingWarrants
6840000 USD
CY2015 gale Issuance Of Common Stock In Exchange Of Outstanding Warrants
IssuanceOfCommonStockInExchangeOfOutstandingWarrants
0 USD
CY2013 gale Issuance Of Common Stock In Settlement Of Contingent Purchase Consideration Milestone
IssuanceOfCommonStockInSettlementOfContingentPurchaseConsiderationMilestone
1247000 USD
CY2015Q4 gale Issuanceof Common Stockfor Litigation Settlement
IssuanceofCommonStockforLitigationSettlement
-1000000 USD
CY2013 gale Issuanceof Common Stockfor Litigation Settlement
IssuanceofCommonStockforLitigationSettlement
0 USD
CY2014 gale Issuanceof Common Stockfor Litigation Settlement
IssuanceofCommonStockforLitigationSettlement
0 USD
CY2015 gale Issuanceof Common Stockfor Litigation Settlement
IssuanceofCommonStockforLitigationSettlement
1000000 USD
CY2013 gale Loss On Warrant Exchange
LossOnWarrantExchange
44001000 USD
CY2014 gale Loss On Warrant Exchange
LossOnWarrantExchange
-16556000 USD
CY2015 gale Loss On Warrant Exchange
LossOnWarrantExchange
-1162000 USD
CY2015 gale Maximum Maturity Period To Consider All Highly Liquid Debt Instruments As Cash And Cash Equivalents
MaximumMaturityPeriodToConsiderAllHighlyLiquidDebtInstrumentsAsCashAndCashEquivalents
P90D
CY2014 gale Maximum Percentage Of Deferred Tax Asset To Establishes Valuation Allowance
MaximumPercentageOfDeferredTaxAssetToEstablishesValuationAllowance
1.00
CY2013 gale Miscellaneous Other Income Expense
MiscellaneousOtherIncomeExpense
37000 USD
CY2014 gale Miscellaneous Other Income Expense
MiscellaneousOtherIncomeExpense
0 USD
CY2015 gale Miscellaneous Other Income Expense
MiscellaneousOtherIncomeExpense
0 USD
CY2013 gale Net Proceeds From Exercise Of Common Stock Warrants
NetProceedsFromExerciseOfCommonStockWarrants
7815000 USD
CY2014 gale Net Proceeds From Exercise Of Common Stock Warrants
NetProceedsFromExerciseOfCommonStockWarrants
10717000 USD
CY2015 gale Net Proceeds From Exercise Of Common Stock Warrants
NetProceedsFromExerciseOfCommonStockWarrants
0 USD
CY2015Q4 gale Numberof Commerical Products
NumberofCommericalProducts
1 products
CY2013Q2 gale Numberof Days Averagedfor Exercise Price
NumberofDaysAveragedforExercisePrice
P20D
CY2015Q4 gale Numberof Dosing Strengths
NumberofDosingStrengths
6 dosing_strength
CY2013Q3 gale Numberof Shares Per Unit
NumberofSharesPerUnit
1 shares
CY2013 gale Operating Lease Expense
OperatingLeaseExpense
77000 USD
CY2014 gale Operating Lease Expense
OperatingLeaseExpense
72000 USD
CY2015 gale Operating Lease Expense
OperatingLeaseExpense
116000 USD
CY2015 gale Proceedsfromsaleofsharesafterspinoff
Proceedsfromsaleofsharesafterspinoff
3911000 USD
CY2014Q4 gale Purchase Agreement Term
PurchaseAgreementTerm
P36M
CY2013 gale Reclassification Of Warrant Liability Upon Exercise
ReclassificationOfWarrantLiabilityUponExercise
14249000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32807000 USD
CY2014 gale Reclassification Of Warrant Liability Upon Exercise
ReclassificationOfWarrantLiabilityUponExercise
27026000 USD
CY2015 gale Sales Discounts Services Percent
SalesDiscountsServicesPercent
0.02
CY2014 gale Shares Issuedfor Milestone Payment
SharesIssuedforMilestonePayment
4381215 shares
CY2014 gale Stock Issued During Period Value Achievementof Milestone
StockIssuedDuringPeriodValueAchievementofMilestone
9340000 USD
CY2013Q2 gale Warrants Granted Numberof Shares
WarrantsGrantedNumberofShares
182186 shares
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1886000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1597000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8885000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5292000 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
821000 USD
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
435000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
256377000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
296730000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
644000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
134000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1886000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
5253000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
2896000 USD
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17130000 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35570000 shares
CY2014Q4 us-gaap Assets
Assets
80488000 USD
CY2015Q4 us-gaap Assets
Assets
82144000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
52100000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
53621000 USD
CY2014Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
27013000 USD
CY2015Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
392000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47787000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23650000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29730000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
30432000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14980000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-24137000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6080000 USD
CY2013 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-15532000 USD
CY2014 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-3056000 USD
CY2015 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
10749000 USD
CY2013 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-5653000 USD
CY2014 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-5832000 USD
CY2015 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-9358000 USD
CY2013Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.47
CY2013Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.50
CY2013Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
0.35 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
14850000 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8540000 shares
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
22308000 shares
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110100701 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162581753 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109425701 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161906753 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
12000 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
15000 USD
CY2015Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
3201000 USD
CY2015Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
4451000 USD
CY2015Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
1516000 USD
CY2015Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
673000 USD
CY2015Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
666000 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15000000 USD
CY2013Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0845
CY2013Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P30M
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
894000 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
332000 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1052000 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
365000 USD
CY2014Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5053000 USD
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5418000 USD
CY2013 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1052000 USD
CY2015 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
365000 USD
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
158000 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
33000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
71325000 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
95477000 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
-5053000 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
-5418000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
53950000 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
75221000 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
200000000 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
183500000 USD
CY2014Q4 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
190000 USD
CY2015Q4 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
1430000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3590000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3866000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4676000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5050000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
71325000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95477000 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
5053000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
5418000 USD
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
35000 USD
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
70000 USD
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
115000 USD
CY2014Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
87000 USD
CY2015Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
171000 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
286000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
362000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
355000 USD
CY2013 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2014 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2015 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-4549000 USD
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1040000 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1535000 USD
CY2013Q2 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.0000
CY2013Q2 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P7Y
CY2013Q2 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.7534
CY2013Q2 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0120
CY2013 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
3911000 USD
CY2014 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
0 USD
CY2015 us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
0 USD
CY2013 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2014 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2015 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-5282000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
5897000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
5898000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
1751000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
1886000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
1303000 USD
CY2012Q4 us-gaap Gross Profit
GrossProfit
2536000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
2357000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
2914000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
1454000 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
1229000 USD
CY2013 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
CY2014 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
CY2015 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
8071000 USD
CY2013 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-71327000 USD
CY2014 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-28284000 USD
CY2015 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-38956000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-70275000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-28284000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-38591000 USD
CY2013 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.79
CY2014 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.24
CY2015 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.25
CY2013 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
5351000 USD
CY2014 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
8322000 USD
CY2015 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
24946000 USD
CY2013 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-5351000 USD
CY2014 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-8322000 USD
CY2015 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-24946000 USD
CY2013 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.06
CY2014 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.07
CY2015 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.16
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1052000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
365000 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11408000 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
17275000 USD
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
24029000 USD
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-25713000 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-12447000 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-21603000 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
813000 USD
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
3996000 USD
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
508000 USD
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
125000 USD
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-996000 USD
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
538000 USD
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-3676000 USD
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1283000 USD
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2375000 USD
CY2013 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
-240000 USD
CY2014 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
42000 USD
CY2015 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
276000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-69000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-21000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-289000 USD
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2811000 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4044000 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3593000 USD
CY2013 us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
302000 USD
CY2014 us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
-2490000 USD
CY2015 us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
-2968000 USD
CY2013 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
0 USD
CY2014 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
0 USD
CY2015 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
21700000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-437000 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1078000 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
245000 USD
CY2013 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
99000 USD
CY2015 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
201000 USD
CY2014Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
0 USD
CY2015Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
21700000 USD
CY2013 us-gaap Interest Paid
InterestPaid
547000 USD
CY2014 us-gaap Interest Paid
InterestPaid
800000 USD
CY2015 us-gaap Interest Paid
InterestPaid
541000 USD
CY2014Q4 us-gaap Interest Payable Current
InterestPayableCurrent
57000 USD
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
28000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
200000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
655000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
0 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
455000 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
211000 USD
CY2014 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2014Q4 us-gaap Liabilities
Liabilities
43429000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
68631000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80488000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82144000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27233000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
57071000 USD
CY2014Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
7169000 USD
CY2015Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4254000 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4492000 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3910000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4739000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24260000 USD
CY2015Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
25000000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
43845000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12040000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5528000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10395000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
3492000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2472000 USD
CY2015Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
5925000 USD
CY2014Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-354000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28929000 USD
CY2015Q4 us-gaap Litigation Settlement Amount
LitigationSettlementAmount
25000000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42869000 USD
CY2013 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
2678000 USD
CY2015 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55949000 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2013 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
3911000 USD
CY2014 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2015 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48160000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-23276000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-37037000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-38802000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-2536000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-19941000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-6173000 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-7506000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-10537000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-15660000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-18026000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-19678000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-76678000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-36606000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-63902000 USD
CY2013 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
CY2014 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
2500000 USD
CY2015 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-41786000 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15616000 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4371000 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
28489000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
43900000 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
34220000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-28489000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-43900000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-34220000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1442000 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
316000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
236000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
251000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
316000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
323000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-78304000 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-36606000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-63902000 USD
CY2013 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
2678000 USD
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 USD
CY2013 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
1626000 USD
CY2013 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
1052000 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
0 USD
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
0 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3022000 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
170000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
509000 USD
CY2015Q4 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
2300000 USD
CY2013 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
CY2014 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
2415000 USD
CY2015 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
10000000 USD
CY2013 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
15532000 USD
CY2014 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3056000 USD
CY2015 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
534000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
320000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
153000 USD
CY2013 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
-3911000 USD
CY2014 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2015 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1237000 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1398000 USD
CY2013 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
19000 USD
CY2014 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
15000 USD
CY2015 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
18000 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
37539000 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10704000 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47416000 USD
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
9865000 USD
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2013Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
35000000 USD
CY2013Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5200000 USD
CY2014 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2300000 USD
CY2015 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2300000 USD
CY2013 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
-1766000 USD
CY2015 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
-3911000 USD
CY2013 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2014 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2015 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
11283000 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
567000 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4342000 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
285000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
335000 USD
CY2013 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
20424000 USD
CY2014 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
27674000 USD
CY2015 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
23611000 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
200000 USD
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
401000 USD
CY2012Q1 us-gaap Sales Revenue Net
SalesRevenueNet
2173000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
2331000 USD
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1620000 USD
CY2012Q4 us-gaap Sales Revenue Net
SalesRevenueNet
3195000 USD
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
2750000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
3382000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
2166000 USD
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
1436000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
2307000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
4666000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1931000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7798
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7937
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7397
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0157
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0201
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0167
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7192000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.22
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2032000 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
6743000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.74
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.07
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
30537000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
610000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
539000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8590000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13262000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.25
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.58
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.79
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.31
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10705000 USD
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.63
CY2013Q3 us-gaap Share Price
SharePrice
2.00
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M28D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M28D
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
16376000 USD
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
509000 USD
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
518000 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y9M4D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M4D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M12D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M2D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M6D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M17D
CY2015 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P10Y
CY2015 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
471869 shares
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
17500000 shares
CY2014 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1400000.0 shares
CY2015 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1400000.0 shares
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
39000 shares
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
22064000 USD
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
37742000 USD
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
163000 USD
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
263000 USD
CY2015 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
309000 USD
CY2013 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
211000 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37539000 USD
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47416000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
567000 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4342000 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
37059000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
13513000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27756000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5886000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37059000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13513000 USD
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
675000 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
675000 shares
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3849000 USD
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3849000 USD
CY2015Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
-485000 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
17400000 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
24000000 USD
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
90181501 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
119388366 shares
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
155264729 shares
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:65px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;font-style:italic;">Concentrations of Credit Risk</font><font style="font-family:Helvetica,sans-serif;font-size:10pt;"> &#8212; Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains cash balances in several accounts with two banks, which at times are in excess of federally insured limits. As of </font><font style="font-family:Helvetica,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Helvetica,sans-serif;font-size:10pt;">, the company&#8217;s cash equivalents were invested in money market mutual funds. The Company&#8217;s investment policy does not allow investment in any debt securities rated less than &#8220;investment grade&#8221; by national ratings services. The Company has not experienced any losses on its deposits of cash and cash equivalents.</font></div></div>
CY2015 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:65px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;font-style:italic;">Reclassifications</font><font style="font-family:Helvetica,sans-serif;font-size:10pt;"> &#8212; Certain prior year amounts have been reclassified to conform to current year presentation. These reclassifications had no effect on net loss per share.</font></div></div>
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:65px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;font-style:italic;">Uses of Estimates in Preparation of Financial Statements</font><font style="font-family:Helvetica,sans-serif;font-size:10pt;"> &#8212; The preparation of these consolidated financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001390478-16-000088-index-headers.html Edgar Link pending
0001390478-16-000088-index.html Edgar Link pending
0001390478-16-000088.txt Edgar Link pending
0001390478-16-000088-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gale-20151231.xml Edgar Link completed
gale-20151231.xsd Edgar Link pending
gale-20151231x10xk.htm Edgar Link pending
gale-20151231xex1037.htm Edgar Link pending
gale-20151231xex1038.htm Edgar Link pending
gale-20151231xex1039.htm Edgar Link pending
gale-20151231xex231.htm Edgar Link pending
gale-20151231xex311.htm Edgar Link pending
gale-20151231xex312.htm Edgar Link pending
gale-20151231xex321.htm Edgar Link pending
gale-20151231_cal.xml Edgar Link unprocessable
gale-20151231_def.xml Edgar Link unprocessable
gale-20151231_lab.xml Edgar Link unprocessable
gale-20151231_pre.xml Edgar Link unprocessable
galena_msrxxtransferagreem.htm Edgar Link pending
gale_sentynl-abstralassetp.htm Edgar Link pending
logo-verticala01.jpg Edgar Link pending
partnerchart3.jpg Edgar Link pending
performancechartv1.jpg Edgar Link pending
pipeline0304.jpg Edgar Link pending
projectblazerassetpurchase.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending